2m 2m 2m 2m 2m 2m 2m
GENPREX (GNPX)
NASDAQ
$5.30-$0.69 (-11.57%)
Price as of Aug 03, 2026 9:03 AM EDT- $3.0MMarket Cap
- -97.64%1-Year Change
- BiotechnologyIndustry
GENPREX (GNPX)
$5.30-$0.69 (-11.57%)
GNPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.99 | ||
Change | -$0.07 (-1.16%) | ||
Open | $6.02 | ||
High | $6.26 | ||
Low | $5.63 | ||
Previous Close | $6.06 | ||
Volume | 28,884 | ||
30-Day Average Volume | 34,487 | ||
1-Week Change | -23.30% | ||
1-Month Change | -47.54% | ||
1-Year Change | -97.64% | ||
3-Year Change | -99.98% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 504,936 | ||
Total Assets | $20.3M | ||
Market Cap | $3.0M | ||
Enterprise Value | -$15.0M | ||
Period: QTR TTM FY | |||
Revenue | $541.00 | ||
Net Income | -$4.5M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$4.5M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $15.4M | ||
EPS | -$14.08 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | -27,772 | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 22 | ||
Last Split Date | 07/16/2026 | ||
Earnings & Revenue